Flavonoids: A review of probable mechanisms of action and potential applications

American Journal of Clinical Nutrition

Volumn 74, Issue 4, 2001, Pages 418-425

  Nijveldt, Robert J ^b   Van Nood, Els ^b   Van Hoorn, Danny E C ^b   Boelens, Petra G ^b   Van Norren, Klaske ^b   Van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Antioxidants; Bioflavonoids; Flavonoids; French paradox; Polyphenols; Review

Indexed keywords

FLAVONOID; QUERCETIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BEVERAGE; CARDIOVASCULAR DISEASE; CHEMICAL MUTAGENESIS; CHEMICAL STRUCTURE; DISEASE ASSOCIATION; DRUG MECHANISM; FAT INTAKE; FOOD ANALYSIS; FOOD PREFERENCE; FRANCE; HUMAN; MORTALITY; POPULATION RISK; REVIEW; TEA; VEGETABLE; WINE;

EID: 0034836506     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/74.4.418     Document Type: Review

References (85)

1. Effect of plant flavonoids on immune and inflammatory cell function
2. Tissue injury by reactive oxygen species and the protective effects of flavonoids
3. Review of the biology of quercetin and related bioflavonoids
4. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study
5. Flavonoid intake and coronary mortality in Finland: A cohort study
6. Bioactivity of flavonoids
7. Structure-antioxidant activity relationships of flavonoids and phenolic acids
8. Reactive oxygen species in tissue injury
9. Ischaemia-reperfusion injury
10. How to characterize an antioxidant: An update
11. Antioxidant and chelating properties of flavonoids
12. The correlation between active oxygens scavenging and antioxidative effects of flavonoids
13. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro
14. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: A new class of renoprotective agents
15. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: An experimental study
16. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion
17. Flavonoids as scavengers of nitric oxide radical
18. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin
19. Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: Preventive effect of some flavonoids
20. Inhibitory effects of flavonoids on xanthine oxidase
21. Effects of flavonoids on xanthine oxidation as well as on cytochrome c reduction by milk xanthine oxidase
22. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers
23. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: In vivo observations in the hamster skin fold
24. Cellular basis of inflammation, edema and the activity of Daflon 500 mg
25. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice
26. Inhibitory effects of natural flavonoids on secretion from mast cells and neutrophils
27. Oxygen radicals in cerebral ischemia
28. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity
29. Protective effect of quercetin and rutin on photosensitized lysis of human erythrocytes in the presence of hematoporphyrin
30. Effects of flavonoids on immune and inflammatory cell functions
31. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids
32. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands
33. Nitric oxide radical scavenging of flavonoids
34. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms
35. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man
36. Absorption and disposition kinetics of the dietary antioxidant quercetin in man
37. Absorption, metabolism and health effects of dietary flavonoids in man
38. Bioavailability of the dietary antioxidant flavonol quercetin in man
39. Dietary flavonoids: Intake, health effects and bioavailability
40. Bioavailability of rutin and quercetin in rats
41. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status
42. Absorption of tea catechins into rat portal vein
43. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin
44. Accumulation of (-)-epicafechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues
45. Inhibition of xanthine oxidase by flavonoids
46. Bracken fern carcinogenesis and quercetin
47. Mutagenic food flavonoids
48. Toxicity and carcinogenicity studies of quercetin, a natural component of foods
49. Catechol-o-methyl transferase catalysis rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo
50. Lack of promotive effect of quercetin on methylazoxymethanol acetate carcinogenesis in rats
51. Absence of overt toxicity from feeding the flavonol, quercetin, to rainbow trout (Salmo gairdneri)
52. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly study
53. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration
54. Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area
55. Intake of flavonoids and risk of dementia
56. Inhibition of sheep platelet arachidonate metabolism by flavonoids from Spanish and Indian medicinal herbs
57. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability
58. Flavonoids: Potent inhibitors of arachidonate 5-lipoxygenase
59. Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs
60. Pro-inflammatory flavonoids which are inhibitors of prostaglandin biosynthesis
61. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids
62. Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase
63. Influence of anti-inflammatory flavonoids on degranulation and arachidonic acid release in rat neutrophils
64. Cancer risk and oxidative DNA damage in man
65. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity
66. Dietary antioxidants and lung cancer risk: A case-control study in Uruguay
67. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis
68. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
69. Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
70. Natural products as angiogenesis inhibitors
71. Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor
72. A study on teapigment in prevention of atherosclerosis
73. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys
74. On the mechanism of antithrombotic action of flavonoids
75. Modification of arachidonic metabolism by flavonoids
76. Inhibition of platelet aggregation by some flavonoids
77. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations
78. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: Comparison with indomethacin and ETYA
79. Tea drinking and bone mineral density in older women
80. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents
81. Antiviral effect of flavonoids on human viruses
82. In vitro inhibitory effect of some flavonoids on rotavirus infectivity
83. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors
84. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection
85. Potential health impacts of excessive flavonoid intake